How have IBIO shares performed in 2024?

iBio's stock was trading at $1.26 at the start of the year. Since then, IBIO stock has increased by 40.5% and is now trading at $1.77. View the best growth stocks for 2024 here .

How were iBio's earnings last quarter?

iBio, Inc. (NYSE:IBIO) posted its quarterly earnings data on Friday, February, 9th. The company reported ($2.42) EPS for the quarter.

What other stocks do shareholders of iBio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iBio investors own include Sorrento Therapeutics (SRNE) , Tesla (TSLA) , Inovio Pharmaceuticals (INO) , T2 Biosystems (TTOO) , Arista Networks (ANET) , Aquestive Therapeutics (AQST) , Alphatec (ATEC) , Alibaba Group (BABA) , Boxlight (BOXL) and Ford Motor (F) .

How do I buy shares of iBio?

Shares of IBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:IBIO

iBio (IBIO) Stock Price, News & Analysis

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)

Free IBIO Stock Alerts

$1.77

-0.12 (-6.35%)

(As of 05:32 PM ET)

Compare

Today's Range: $1.73
▼
$1.90
50-Day Range: N/A
52-Week Range: $1.02
▼
$28.20

Volume: 180,253 shs
Average Volume: 3.23 million shs
Market Capitalization: $6.16 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Earnings Financials SEC Filings Social Media

Get iBio alerts:

Ad Insiders Exposed

This consistently signaled gains of 453%... 610%... and even 1036%...

It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.

About iBio Stock (NYSE:IBIO)

iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel. The company is also developing vaccine candidates, including IBIO-101, an antibody to reduce tumor growth; Endostatin E4 peptide for use in chemotherapy and immunotherapy; Trop-2 for the treatment Trop-2 positive cancers; MUC16, a tumor-associated epitope; anti-EGFRvIII antibody to treat glioblastoma and other cancers; CCR8 protein candidate for treatment of various cancers; PD-1 agonist for the treatment of rheumatoid arthritis and other inflammatory diseases; and IBIO-400 for the treatment of classical swine fever. iBio, Inc. has agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; and a research collaboration with the National Institute of Allergy and Infectious Diseases to investigate the potential of the company's AI-driven epitope steering platform for the development of a vaccine for Lassa fever. The company was incorporated in 2008 and is headquartered in Bryan, Texas.

IBIO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IBIO Stock News Headlines

April 12, 2024 | americanbankingnews.com

StockNews.com Initiates Coverage on iBio (NYSE:IBIO)

April 5, 2024 | investorplace.com

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

April 18, 2024 | DTI (Ad)

With the “Bitcoin Loophole” you can supercharge the gains by 10x or more

Thanks to this newly discovered Bitcoin Loophole, you can now trade Bitcoin in any regular brokerage account… And not only that… you can use it to supercharge the gains of Bitcoin by 10x or more! You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history. That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords…

March 28, 2024 | markets.businessinsider.com

Kodiak Sciences Inc Registered Shs hosts conference call for investors

See More Headlines

Receive IBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iBio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/09/2024
Today: 4/18/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NYSE:IBIO
CUSIP: N/A
CIK: 1420720
Web: www.ibioinc.com
Phone: 302-355-0650
Fax: 302-356-1173
Employees: 26
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-65,010,000.00
Net Margins: N/A
Pretax Margin: -41,546.00%
Return on Equity: -150.59%
Return on Assets: -52.83%

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 0.91
Quick Ratio: 0.91

Sales & Book Value

Annual Sales: $2.38 million
Price / Sales: 2.59
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $15.15 per share
Price / Book: 0.12

Miscellaneous

Outstanding Shares: 3,480,000
Free Float: 3,445,000
Market Cap: $6.16 million
Optionable: N/A
Beta: -3.51

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Dr. Martin B. Brenner D.V.M. (Age 53)
Ph.D., CEO & Chief Scientific Officer
Comp: $577.31k
Mr. Felipe Duran (Age 44)
Chief Financial Officer
Comp: $1.07M
Stephen Kilmer
Investor Relations Officer
Mr. Marc Banjak J.D.
General Counsel
Mr. Robert B. Kay (Age 84)
Interim Secretary & Interim Treasurer
Comp: $92.69k

Key Competitors

View All Competitors

IBIO Stock Analysis - Frequently Asked Questions

How have IBIO shares performed in 2024?: iBio's stock was trading at $1.26 at the start of the year. Since then, IBIO stock has increased by 40.5% and is now trading at $1.77.
View the best growth stocks for 2024 here.
How were iBio's earnings last quarter?: iBio, Inc. (NYSE:IBIO) posted its quarterly earnings data on Friday, February, 9th. The company reported ($2.42) EPS for the quarter.
What other stocks do shareholders of iBio own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iBio investors own include Sorrento Therapeutics (SRNE), Tesla (TSLA), Inovio Pharmaceuticals (INO), T2 Biosystems (TTOO), Arista Networks (ANET), Aquestive Therapeutics (AQST), Alphatec (ATEC), Alibaba Group (BABA), Boxlight (BOXL) and Ford Motor (F).
How do I buy shares of iBio?: Shares of IBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:IBIO) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial